# Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR

> **NCT00521040** · NA · COMPLETED · sponsor: **UCB Pharma** · enrollment: 459 (actual)

## Conditions studied

- Rhinitis, Allergic, Seasonal

## Interventions

- **DRUG:** Levocetirizine dihydrochloride

## Key facts

- **NCT ID:** NCT00521040
- **Lead sponsor:** UCB Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-02
- **Primary completion:** 2004-07
- **Final completion:** 2004-07
- **Target enrollment:** 459 (ACTUAL)
- **Last updated:** 2013-12-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00521040

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00521040, "Efficacy and Safety of Levocetirizine 8 Weeks Prior and After the Onset of the Grass Pollen Season in Subjects With SAR". Retrieved via AI Analytics 2026-07-26 from https://api.ai-analytics.org/clinical/NCT00521040. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*